Literature DB >> 2143698

Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

D Michalovitz1, O Halevy, M Oren.   

Abstract

Mutant p53 can contribute to transformation, while wild-type (wt) p53 is not oncogenic and actually inhibits transformation. Furthermore, wt p53 may act as a suppressor gene in human carcinogenesis. We now describe the temperature-sensitive behavior of a particular mutant, p53val135. Like other p53 mutants, it can elicit transformation at 37.5 degrees C. However, at 32.5 degrees C it suppresses transformation, behaving like authentic wt p53. Moreover, the proliferation of transformed cells expressing p53val135 is dramatically inhibited at the permissive temperature. Significantly, the inhibition of both transformation and proliferation is reversible upon temperature upshift. These data demonstrate that the ability of wt p53 to suppress transformation is not due to a general lethal effect, but rather to a reversible growth arrest. p53val135 may prove instrumental for gaining insight into the cellular and molecular properties of wt p53.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143698     DOI: 10.1016/0092-8674(90)90113-s

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  253 in total

1.  p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.

Authors:  J N Harada; A J Berk
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin.

Authors:  J Lotem; R Kama; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

3.  Middle T antigen activation of signal transduction pathways does not overcome p53-mediated growth arrest.

Authors:  J Doherty; R Freund
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  The G(2) checkpoint is maintained by redundant pathways.

Authors:  T M Passalaris; J A Benanti; L Gewin; T Kiyono; D A Galloway
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

5.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays.

Authors:  R Zhao; K Gish; M Murphy; Y Yin; D Notterman; W H Hoffman; E Tom; D H Mack; A J Levine
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

Review 6.  Hsp70 interactions with the p53 tumour suppressor protein.

Authors:  M Zylicz; F W King; A Wawrzynow
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

7.  Involvement of retinoblastoma protein and HBP1 in histone H1(0) gene expression.

Authors:  C Lemercier; K Duncliffe; I Boibessot; H Zhang; A Verdel; D Angelov; S Khochbin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

8.  Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53.

Authors:  M M Sugrue; D Y Shin; S W Lee; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 9.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

10.  Conditional JAG1 mutation shows the developing heart is more sensitive than developing liver to JAG1 dosage.

Authors:  Fengmin Lu; Jennifer J D Morrissette; Nancy B Spinner
Journal:  Am J Hum Genet       Date:  2003-03-14       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.